BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29808375)

  • 1. Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us?
    Zanoni A; Verlato G; Baiocchi GL; Casella F; Cossu A; d'Ignazio A; De Pascale S; Giacopuzzi S
    Updates Surg; 2018 Jun; 70(2):241-249. PubMed ID: 29808375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siewert III adenocarcinoma: treatment update.
    Di Leo A; Zanoni A
    Updates Surg; 2017 Sep; 69(3):319-325. PubMed ID: 28303519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Clinical Stage in the 8
    Watanabe H; Hasegawa S; Kumazu Y; Hashimoto I; Komori K; Suematsu H; Kano K; Fujikawa H; Aoyama T; Yamada T; Yukawa N; Yoshikawa T; Rino Y; Saito A; Ogata T; Oshima T
    In Vivo; 2023; 37(4):1790-1796. PubMed ID: 37369497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
    Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
    Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
    Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Therapeutic Implications of the 8th Edition TNM Classification of Adenocarcinomas of the Esophagogastric Junction.
    Birla R; Gandea C; Hoara P; Caragui A; Marica C; Vasiliu E; Constantinoiu S
    Chirurgia (Bucur); 2018; 113(6):747-757. PubMed ID: 30596362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification.
    Suh YS; Han DS; Kong SH; Lee HJ; Kim YT; Kim WH; Lee KU; Yang HK
    Ann Surg; 2012 May; 255(5):908-15. PubMed ID: 22504190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic value of AJCC cancer staging system 7th and 8th editions for differentiated thyroid cancer.
    Morosán Allo YJ; Bosio L; Morejón A; Parisi C; Faingold MC; Ilera V; Gauna A; Brenta G
    BMC Endocr Disord; 2022 Jun; 22(1):146. PubMed ID: 35650574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
    Anticancer Res; 2013 Aug; 33(8):3461-5. PubMed ID: 23898120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
    Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
    Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
    World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
    Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
    Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How applicable is the TNM 8 staging for human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) to a UK population of 106 patients? : A cohort comparison of the TNM 7 and TNM8 staging systems for HPV positive oropharyngeal cancer in a UK population.
    Bradish T; Fisher H; Paleri V; Robinson M; Meikle D; Kelly C; O'Hara J
    Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):755-761. PubMed ID: 32621245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.
    Kim HI; Cheong JH; Song KJ; An JY; Hyung WJ; Noh SH; Kim CB
    Ann Surg Oncol; 2013 Aug; 20(8):2713-20. PubMed ID: 23456315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.